These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 8757421)

  • 1. Antiviral efficacy and toxicity of ribavirin in murine acquired immunodeficiency syndrome model.
    Harvie P; Omar RF; Dusserre N; Désormeaux A; Gourde P; Tremblay M; Beauchamp D; Bergeron MG
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Aug; 12(5):451-61. PubMed ID: 8757421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ribavirin potentiates the efficacy and toxicity of 2',3'- dideoxyinosine in the murine acquired immunodeficiency syndrome model.
    Harvie P; Omar RF; Dusserre N; Lansac N; Désormeaux A; Gourde P; Simard M; Tremblay M; Beauchamp D; Bergeron MG
    J Pharmacol Exp Ther; 1996 Nov; 279(2):1009-17. PubMed ID: 8930211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral efficacy and toxicity of ribavirin and foscarnet each given alone or in combination in the murine AIDS model.
    Omar RF; Harvie P; Gourde P; Désormeaux A; Tremblay M; Beauchamp D; Bergeron MG
    Toxicol Appl Pharmacol; 1997 Mar; 143(1):140-51. PubMed ID: 9073602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of the murine, retrovirus-induced lymphoproliferative immunodeficiency disease (LP-BM5) in C57BL/10 mice with the immunomodulator Imexon.
    Funk CY; Eisman J; Hersh EM
    AIDS Res Hum Retroviruses; 1992 May; 8(5):633-8. PubMed ID: 1515214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of murine AIDS (MAIDS) development in C57BL/6J mice by tyrphostin AG-1387.
    Sklan EH; Gazit A; Priel E
    Virology; 2000 Dec; 278(1):95-102. PubMed ID: 11112485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose response and timing effects in the therapy of the LP-BM5 murine retrovirus-induced lymphoproliferative immunodeficiency disease with diethyldithiocarbamate.
    Hersh EM; Funk CY; Petersen EA; Ryschon KL; Mosier DE
    Int J Immunopharmacol; 1993 Feb; 15(2):137-43. PubMed ID: 8385652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the CD154-positive and CD40-positive cellular subsets required for pathogenesis in retrovirus-induced murine immunodeficiency.
    Green KA; Noelle RJ; Durell BG; Green WR
    J Virol; 2001 Apr; 75(8):3581-9. PubMed ID: 11264347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Z-100, a Mycobacterium-tuberculosis-derived arabinomannan, on the LP-BM5 murine leukemia virus infection in mice.
    Sasaki H; Kobayashi M; Pollard RB; Suzuki F
    Pathobiology; 2001; 69(2):96-103. PubMed ID: 11752903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for a continued requirement for CD40/CD40 ligand (CD154) interactions in the progression of LP-BM5 retrovirus-induced murine AIDS.
    Green KA; Noelle RJ; Green WR
    Virology; 1998 Feb; 241(2):260-8. PubMed ID: 9499800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD19 signaling pathways play a major role for murine AIDS induction and progression.
    Knoetig SM; Torrey TA; Naghashfar Z; McCarty T; Morse HC
    J Immunol; 2002 Nov; 169(10):5607-14. PubMed ID: 12421939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effects of Curcuma longa L., Purple Sweet Potato, and Mixtures of the Two on Immunomodulation in C57BL/6J Mice Infected with LP-BM5 Murine Leukemia Retrovirus.
    Park SJ; Lee D; Lee M; Kwon HO; Kim H; Park J; Jeon W; Cha M; Jun S; Park K; Lee J
    J Med Food; 2018 Jul; 21(7):689-700. PubMed ID: 29862890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of murine AIDS by combination of AZT and dideoxycytidine 5'-triphosphate.
    Fraternale A; Casabianca A; Rossi L; Chiarantini L; Brandi G; Aluigi G; Schiavano GF; Magnani M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1996 Jun; 12(2):164-73. PubMed ID: 8680888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic effects of glycyrrhizin in mice infected with LP-BM5 murine retrovirus and mechanisms involved in the prevention of disease progression.
    Watanbe H; Miyaji C; Makino M; Abo T
    Biotherapy; 1996; 9(4):209-20. PubMed ID: 9012540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody to the ligand for CD40 (gp39) inhibits murine AIDS-associated splenomegaly, hypergammaglobulinemia, and immunodeficiency in disease-susceptible C57BL/6 mice.
    Green KA; Crassi KM; Laman JD; Schoneveld A; Strawbridge RR; Foy TM; Noelle RJ; Green WR
    J Virol; 1996 Apr; 70(4):2569-75. PubMed ID: 8642687
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of lithium in murine immunodeficiency virus infected animals.
    Gallicchio VS; Cibull ML; Hughes NK; Tse KF
    Pathobiology; 1993; 61(3-4):216-21. PubMed ID: 8216844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of spleen cell subsets by chronic cocaine administration and murine retrovirus infection in normal and protein-malnourished mice.
    Lopez MC; Chen GJ; Huang DS; Wang Y; Watson RR
    Int J Immunopharmacol; 1992 Oct; 14(7):1153-63. PubMed ID: 1452400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral effect of combined zidovudine and reduced glutathione therapy in murine AIDS.
    Magnani M; Fraternale A; Casabianca A; Schiavano GF; Chiarantini L; Palamara AT; Ciriolo MR; Rotilio G; Garaci E
    AIDS Res Hum Retroviruses; 1997 Sep; 13(13):1093-9. PubMed ID: 9282814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of ex-vivo cytokine production by splenocytes during murine acquired immunodeficiency syndrome (MAIDS).
    Akarid K; Pocidalo MA; Desforges B; Sinet M
    Eur Cytokine Netw; 1995; 6(3):181-5. PubMed ID: 8589275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of murine retrovirus-induced immunodeficiency disease by dideoxycytidine and dideoxycytidine 5'-triphosphate.
    Rossi L; Brandi G; Fraternale A; Schiavano GF; Chiarantini L; Magnani M
    J Acquir Immune Defic Syndr (1988); 1993 Nov; 6(11):1179-86. PubMed ID: 8229653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo exposure to ultraviolet radiation enhances pathogenic effects of murine leukemia virus, LP-BM5, in murine acquired immunodeficiency syndrome.
    Brozek CM; Shopp GM; Ryan SL; Gillespie PM; Kusewitt DF; Rajagopalan MS; Ley KD; Ley RD
    Photochem Photobiol; 1992 Sep; 56(3):287-95. PubMed ID: 1332087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.